Campbell & Co Investment Adviser’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
+18,787
New +$1.93M 0.09% 356
2026
Q1
Sell
-5,278
Closed -$428K 1260
2025
Q4
$428K Sell
5,278
-4,443
-46% -$382K 0.02% 878
2025
Q3
$851K Buy
+9,721
New +$868K 0.06% 485
2024
Q2
Sell
-6,132
Closed -$407K 1214
2024
Q1
$407K Sell
6,132
-4,670
-43% -$288K 0.04% 792
2023
Q4
$613K Buy
10,802
+5,473
+103% +$287K 0.06% 616
2023
Q3
$290K Buy
5,329
+2,349
+79% +$139K 0.03% 729
2023
Q2
$200K Sell
2,980
-4,198
-58% -$256K 0.04% 807
2023
Q1
$369K Buy
+7,178
New +$348K 0.07% 533
2022
Q2
Sell
-4,733
Closed -$220K 807
2022
Q1
$220K Buy
+4,733
New +$212K 0.06% 591
2021
Q2
Sell
-6,000
Closed -$293K 631
2021
Q1
$293K Buy
+6,000
New +$281K 0.18% 237
2020
Q1
Sell
-5,890
Closed -$212K 293
2019
Q4
$212K Buy
+5,890
New +$203K 0.07% 566
2018
Q2
Sell
-23,666
Closed -$857K 462
2018
Q1
$857K Buy
+23,666
New +$820K 0.72% 9
2017
Q4
Sell
-6,704
Closed -$251K 461
2017
Q3
$251K Buy
+6,704
New +$228K 0.2% 214
2017
Q1
Sell
-8,046
Closed -$204K 186
2016
Q4
$204K Buy
+8,046
New +$179K 0.63% 95

Other funds holding LMAT

Campbell & Co Investment Adviser's LMAT Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 18,787 shares worth $1.8M. The stake represents 0.09% of the portfolio and ranks #356 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in LMAT as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in LMAT in Q4 2016 and has held it in 14 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Campbell & Co Investment Adviser held 18,787 shares of LeMaitre Vascular worth $1.8M as of Q2 2026.
  • LeMaitre Vascular was a new Campbell & Co Investment Adviser position in Q2 2026.
  • LeMaitre Vascular made up 0.09% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #356 holding.
  • Campbell & Co Investment Adviser first reported a position in LeMaitre Vascular in Q4 2016 and has held it in 14 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.